Acute Porphyria Drugs

B01AC17 - Tirofiban

Not Porphyrinogenic
NP

Rationale
No data pointing to CYP-interactions.
Chemical description
Butylsulfonyl phenyalanine platelet inhibitor. Given together with ASA and heparin as intravenous infusion 0.4 ug/kg BW/ min to prevent early infarction in instable angina and other cardiac conditions.
Similar drugs
Explore alternative drugs in similar therapeutic classes
  • B01A ANTITHROMBOTIC AGENTS
  • B01AC Platelet Aggregation Inhibitors Excl. Heparin
References
Tradenames

Aggrastat · Tirofiban Aggrastat Agrastat · Tirofiban Aggrastat Aggrastat · Tirofiban Aggrastat Aggrastat · Tirofiban Aggrastat Tirofiban Agrastat · Iniplaq · Plasminase · Tirofiban Aggrastat Aggrastat Aggrastat Aggrastat Aggrastat · Trombopriv Aggrastat Aggrastat · Trombopriv Aggrastat · Tirofiban · Trombopriv Tirofiban
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙